Next Article in Journal
25-Hydroxycholesterol-Induced Oxiapoptophagy in L929 Mouse Fibroblast Cell Line
Next Article in Special Issue
Plants as a Source of Anticancer Agents: From Bench to Bedside
Previous Article in Journal
Zizaane-Type Sesquiterpenoids and Their Rearranged Derivatives from Agarwood of an Aquilaria Plant
Previous Article in Special Issue
Synthesis of Tyrosol and Hydroxytyrosol Glycofuranosides and Their Biochemical and Biological Activities in Cell-Free and Cellular Assays
 
 
Review
Peer-Review Record

A Double-Edged Sword: Thioxanthenes Act on Both the Mind and the Microbiome

Molecules 2022, 27(1), 196; https://doi.org/10.3390/molecules27010196
by Marianne Ø. Poulsen 1,*, Sujata G. Dastidar 2,†, Debalina Sinha Roy 2, Shauroseni Palchoudhuri 2, Jette Elisabeth H. Kristiansen 1,† and Stephen J. Fey 3
Reviewer 1: Anonymous
Reviewer 2: Anonymous
Molecules 2022, 27(1), 196; https://doi.org/10.3390/molecules27010196
Submission received: 11 September 2021 / Revised: 6 November 2021 / Accepted: 8 November 2021 / Published: 29 December 2021

Round 1

Reviewer 1 Report

A double-edged sword: thioxanthenes act on both the mind and the microbiome

This is an interesting and detailed review of the pharmacological properties of thioxanthenes that reveals a great diversity of the therapeutic use of these substances. A detailed analysis of the chemical structure of thioxanthenes related to their therapeutic activity and their adverse effects compared to phenothiazines and butyphenones is presented. These drugs have "non-antibiotic" effects on endogenous myco-organisms and have synergistic effects with the classic antibiotics. This article is well presented with an extensive up-to-date bibliography. Its reading is easy and understandable.

Author Response

Thank you very much for your positive comments. In accordance to the comments from Reviewer 2, we have made changes. Please see the attachments.

Author Response File: Author Response.pdf

Reviewer 2 Report

 

The comments regarding the manuscript entitled: A double-edged Sword: “Thioxanthenes Act on Both the Mind  and the Microbiome” are presented below.

The subject of  this article is interesting and could be useful for the researchers involved in this field of science. Due to this fact I consider that supplementary information and improvements are necessary.

 

Taking into consideration the observations below I recommend the publication of this manuscript after major revision.

In the article the comparation with phenothiazine derivatives is always presented, so why phenothiazine  it is not mentioned in the title?  

The literature is old, I found an article from 2019, four from 2017, three from 2016. The question is if the subject it is not interesting for the researcher, or the literature was not exhaustively investigated? 

 

Line 69: Due to structural similarity, the antipsychotic activities  of flupenthixol and clopenthixol are quite similar to the phenothiazine class (also known  as the ‘piperazine group’).

Comment: From the structural point of view the Phenothiazine could not be considered in the “piperazine group” because the phenothiazine is a 1,4-thiazine derivative, not piperazine. 

 

Line 130: However, it is possible to prolong the activity by substituting F in position 6.

 

Comment: Please be more specific, regarding the substituents able to prolong the activity.

 

Line 143: Neuroleptics are known for their α-adrenolytic function. Between phenothiazines  and thioxanthenes, the adrenolytic activity was found to be more prominent in the cis-isomers of chlorprothixene, flupenthixol and clopenthixol while chlorpromazine and  fluphenazine revealed much less activity.

Comment: The recommended IUPAC nomenclature is Z, E and not cis trans in the case of the presented compounds.

Comment: Please rephrase de sentence, in the  structure of chlorpromazine and  fluphenazine  we do not have C=C double bond so they do not present Z/E isomers like cis-isomers of chlorprothixene, flupenthixol and clopenthixol.

 

Line 168 Several reports indicate the connection of gut bacteria with the development of neurodegenerative 169 diseases, (like Alzheimer’s, Parkinson’s and Schizophrenia), with their associated cognitive decline.

Comment:  Please indicate the scientific literature 

 

Line 180: Although many of the non-antibiotics are tricyclic phenothiazines[40] there are compounds that possess two benzene rings which are joined to each  other by different structural moieties

Comment: The phenothiazine has two benzene rings connected by nitrogen and sulphur atoms and even though it is a tricyclic structure the ‘tricyclic phenothiazines’ sounds odd.

Line 185-202& all document: Of the two  stereo-isomeric compounds, trans(E)-clopenthixol, showed much greater antibacterial  action than cis(Z)-clopenthixol 

Comments: Only E/Z nomenclature is suitable, not trans(E) or cis (Z)

 

Line224: the two stereo chemical variants. 

Comment:  stereo isomers not chemical variants

 

Figure 2: Mechanism of action of 20 μg/mL flupenthixol on Vibrio cholerae 1347 (minimum inhibi tory concentration of 10 μg/mL. Adapted from: Jeyaseeli et al 2006

 

Comment: The figure 2 does not present a mechanism of action, it presents only the decrease of cells viability in time

In the paragraph “Mechanism of antibacterial action of thioxanthenes” there is not presented information related with the Mechanism of antibacterial action…, the mechanism is missing.

 

Line 348: To determine cell growth inhibition, 24-well multidishes were seeded with 50,000  fibroblasts per well in 1 ml of growth medium, with or without test compounds. When 349 the cells in the control wells formed a monolayer, the multidishes were washed, fixed, 350 stained with crystal violet and visualized in a spectrophotometer at 570 nm[…

 

Comment:

In a review article I do not consider adequate to present a detailed experimental protocol; this is only an example but there are many others in the manuscript. 

 

 

Author Response

Thank you for your constructive comments. We have made the suggested changes so please see the attachment for our Cover letter

Author Response File: Author Response.pdf

Round 2

Reviewer 2 Report

The article can be published in its current form.

Author Response

Please see the attachment

Author Response File: Author Response.docx

Back to TopTop